A PET scan (positron emission tomography) is an imaging test that reveals how your tissues and organs are functioning at the cellular level, rather than just showing their structure. It’s most commonly used in cancer care to determine whether a tumor has spread, how well treatment is working, or whether cancer has returned. But it also plays important roles in diagnosing heart disease and brain conditions like Alzheimer’s.
How a PET Scan Creates Images
Before the scan, you receive an injection of a radioactive tracer, a sugar-based compound that your cells absorb as fuel. Cancer cells, inflamed tissue, and other highly active cells consume more of this sugar than healthy ones, so they light up on the scan. The tracer contains a tiny amount of radioactive material that emits particles called positrons. When a positron collides with a nearby electron, both are destroyed and release two bursts of energy (gamma rays) that fly off in exactly opposite directions. The scanner’s ring of detectors picks up these paired signals and pinpoints where in your body each collision happened.
A computer assembles millions of these data points into a detailed 3D map of metabolic activity. Areas that absorbed more tracer glow brighter on the image, giving your doctor a visual guide to where cells are most active.
Why PET Scans Are Paired With CT or MRI
A PET scan on its own shows cellular activity but lacks sharp anatomical detail. That’s why nearly all PET scans today are performed as combination exams. PET/CT is the most common pairing: the CT component provides a detailed structural image and also helps the computer correct for how the body absorbs radiation, which improves accuracy. The two scans happen back to back on the same machine, and the images are overlaid so your doctor can see both what’s happening and exactly where.
PET/MRI is a newer alternative that offers better soft-tissue contrast, sharper motion correction (using breath-hold data from MRI sequences), and significantly less radiation. In studies comparing the two, PET/MRI delivered an average effective dose of about 3.6 millisieverts compared to roughly 17.6 millisieverts for PET/CT, a reduction of nearly 80%. PET/MRI is especially useful for brain, liver, and pelvic imaging, where MRI’s soft-tissue detail matters most.
Cancer Diagnosis and Monitoring
Oncology is where PET scans have their biggest impact. The scan can reveal whether cancer has spread to lymph nodes or distant organs, a process called staging that directly shapes treatment decisions. National Comprehensive Cancer Network guidelines recommend PET/CT for initial staging of lung cancer, for restaging after treatment, and for planning radiation therapy. The same principles apply across many cancer types: lymphoma, head and neck cancers, melanoma, esophageal cancer, and colorectal cancer all benefit from PET imaging.
During and after treatment, repeat PET scans show whether tumors are responding to chemotherapy or radiation. A tumor that was previously bright on the scan but dims after a few cycles of treatment is a strong signal that therapy is working. This gives oncologists real-time feedback they can act on, sometimes changing a treatment plan mid-course if the scan shows the cancer isn’t responding.
Brain and Neurological Uses
PET scans can detect the protein plaques that define Alzheimer’s disease years before symptoms become severe. These amyloid plaques, sticky protein deposits that build up between nerve cells, are a hallmark of Alzheimer’s. Since 2004, specialized tracers have been developed that bind directly to these plaques and make them visible on the scan. Three of these tracers are now commercially available and can be shipped from production facilities to imaging centers, making amyloid PET accessible beyond major research hospitals.
This type of scan is particularly valuable when a diagnosis is uncertain. It can distinguish Alzheimer’s from other forms of dementia, like frontotemporal dementia, that don’t involve amyloid buildup. It’s also useful in cases of mild cognitive impairment, helping determine whether an underlying Alzheimer’s process is responsible. Newer tracers can also detect tau, a second abnormal protein involved in Alzheimer’s, giving researchers and clinicians two independent biological markers to track.
Heart Disease Assessment
In cardiology, PET scans measure blood flow through the heart muscle with a precision no other imaging method matches. The scan uses a different tracer (a potassium-like compound) that flows through coronary arteries and is absorbed by heart tissue. By comparing blood flow at rest and under stress, the scan can identify blocked or narrowed arteries and quantify exactly how much flow is restricted, measured in milliliters per gram of heart tissue per minute.
This quantitative ability is especially important for people with diabetes. Research has shown that diabetic patients without known heart disease but with reduced coronary flow reserve (the heart’s ability to increase blood flow during exertion) have cardiac event rates comparable to people who already have established coronary artery disease. In other words, the PET scan can catch a serious problem before it causes a heart attack, even when other tests look normal.
Beyond the Sugar Tracer
The standard tracer is a radioactive sugar (FDG), but it’s not the only option. Different tracers target different biological processes. One tracks cell division rather than sugar consumption, which helps grade lung tumors and evaluate brain cancers. An amino acid-based tracer has shown promise in brain tumor imaging, where the normal brain’s high sugar use can make FDG scans harder to interpret. For prostate cancer, specialized tracers that detect fat metabolism can identify both primary tumors and metastatic disease that FDG might miss.
What to Expect Before the Scan
Preparation centers on keeping your blood sugar stable and low so the tracer goes where it’s needed, not into muscles that just processed a meal. You’ll fast for 12 hours before your appointment, drinking only plain water. No gum, mints, candy, vitamins, or syrup-based medications during the fast, as even small amounts of sugar can interfere with the results. If you take insulin at bedtime, you can still take your usual dose, but have a high-protein snack before the fasting window begins. Eat normal meals the day and evening before.
What Happens During and After
The tracer is injected into a vein in your arm, and then you wait. Guidelines recommend a 60-minute uptake period (with an acceptable window of 55 to 75 minutes) to let the tracer distribute through your body and concentrate in active cells. During this time, you’ll sit or lie quietly. Physical activity, even fidgeting, can cause muscles to absorb more tracer and muddy the images.
The scan itself typically takes 20 to 40 minutes. You lie on a narrow table that slides through a ring-shaped scanner. It’s painless and quieter than an MRI. Afterward, the radioactive tracer breaks down quickly in your body and is flushed out through urine over the next several hours. You can eat and drink normally right away.
The radiation exposure from a standard PET/CT is about 17 to 18 millisieverts on average, roughly equivalent to several years of natural background radiation compressed into one exam. As a precaution, you may be advised to avoid prolonged close contact with pregnant women, babies, or young children for a few hours after the scan, since your body will be mildly radioactive until the tracer fully decays.